Evelyn Mei Huang

Array ( [id] => 1178045 [patent_doc_number] => 06743786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-01 [patent_title] => 'Vanadium compounds for treating cancer' [patent_app_type] => B2 [patent_app_number] => 10/142305 [patent_app_country] => US [patent_app_date] => 2002-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 22 [patent_no_of_words] => 24285 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/743/06743786.pdf [firstpage_image] =>[orig_patent_app_number] => 10142305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1037581 [patent_doc_number] => 06872730 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-29 [patent_title] => 'Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists' [patent_app_type] => utility [patent_app_number] => 10/132706 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16078 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/872/06872730.pdf [firstpage_image] =>[orig_patent_app_number] => 10132706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112852 [patent_doc_number] => 20020173520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Quinoline derivatives' [patent_app_type] => new [patent_app_number] => 10/131177 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7920 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173520.pdf [firstpage_image] =>[orig_patent_app_number] => 10131177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874926 [patent_doc_number] => 20030195223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Antithrombotic agents' [patent_app_type] => new [patent_app_number] => 10/133907 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27762 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20030195223.pdf [firstpage_image] =>[orig_patent_app_number] => 10133907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112841 [patent_doc_number] => 20020173519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Quinoline derivatives' [patent_app_type] => new [patent_app_number] => 10/131176 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8749 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173519.pdf [firstpage_image] =>[orig_patent_app_number] => 10131176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688923 [patent_doc_number] => 20030032648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => '8-Aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benodioxan as 5-HT1A antagonists' [patent_app_type] => new [patent_app_number] => 10/128057 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7035 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032648.pdf [firstpage_image] =>[orig_patent_app_number] => 10128057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6414181 [patent_doc_number] => 20020183355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine' [patent_app_type] => new [patent_app_number] => 10/127923 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5178 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183355.pdf [firstpage_image] =>[orig_patent_app_number] => 10127923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1232013 [patent_doc_number] => 06693198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Amonafide salts' [patent_app_type] => B2 [patent_app_number] => 10/128129 [patent_app_country] => US [patent_app_date] => 2002-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5854 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693198.pdf [firstpage_image] =>[orig_patent_app_number] => 10128129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6451279 [patent_doc_number] => 20020177603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Tricyclic compounds useful as HIV reverse transcriptase inhibitors' [patent_app_type] => new [patent_app_number] => 10/124105 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12064 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177603.pdf [firstpage_image] =>[orig_patent_app_number] => 10124105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1216838 [patent_doc_number] => 06706730 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-16 [patent_title] => '1,4,5,6-tetrahydropyrazolo-3,4-c-pyridin-7-ones as factor Xa inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/124360 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9425 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706730.pdf [firstpage_image] =>[orig_patent_app_number] => 10124360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1173503 [patent_doc_number] => 06750225 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-15 [patent_title] => '1,4,5,6-tetrahydropyrazolo-3,4,-c-pyridin-7-ones useful as factor Xa inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/124383 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19947 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750225.pdf [firstpage_image] =>[orig_patent_app_number] => 10124383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1139962 [patent_doc_number] => 06780998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-24 [patent_title] => 'Substituted 2-aminoalkyl-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same' [patent_app_type] => B2 [patent_app_number] => 10/124149 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11279 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 477 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780998.pdf [firstpage_image] =>[orig_patent_app_number] => 10124149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1281946 [patent_doc_number] => 06642246 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Quinuclidine acrylamides' [patent_app_type] => B1 [patent_app_number] => 10/110663 [patent_app_country] => US [patent_app_date] => 2002-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6372 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642246.pdf [firstpage_image] =>[orig_patent_app_number] => 10110663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721355 [patent_doc_number] => 20030055045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Novel compounds with analgesic effect' [patent_app_type] => new [patent_app_number] => 10/121683 [patent_app_country] => US [patent_app_date] => 2002-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12570 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055045.pdf [firstpage_image] =>[orig_patent_app_number] => 10121683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1220882 [patent_doc_number] => 06703404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-09 [patent_title] => 'Tert -butyl-(7-methyl-imidazol 1,2-apyridin-3-yl)-amine derivatives' [patent_app_type] => B2 [patent_app_number] => 10/117339 [patent_app_country] => US [patent_app_date] => 2002-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8477 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 271 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703404.pdf [firstpage_image] =>[orig_patent_app_number] => 10117339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6693095 [patent_doc_number] => 20030040527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => '1-substituted 1,2,3,4-tetrahydro-beta-carboline and 3,4-dihydro-beta-carboline and analogs as antitumor agents' [patent_app_type] => new [patent_app_number] => 10/115312 [patent_app_country] => US [patent_app_date] => 2002-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11935 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040527.pdf [firstpage_image] =>[orig_patent_app_number] => 10115312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6474569 [patent_doc_number] => 20020151569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'PPAR gamma ligands' [patent_app_type] => new [patent_app_number] => 10/115550 [patent_app_country] => US [patent_app_date] => 2002-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7653 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151569.pdf [firstpage_image] =>[orig_patent_app_number] => 10115550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1228715 [patent_doc_number] => 06696460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-24 [patent_title] => 'Tetrahydropyridoethers' [patent_app_type] => B2 [patent_app_number] => 10/103733 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5996 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 271 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696460.pdf [firstpage_image] =>[orig_patent_app_number] => 10103733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7612724 [patent_doc_number] => 06903111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-07 [patent_title] => 'Isoquinuclidine derivative process for producing the same, and medicinal composition containing the same' [patent_app_type] => utility [patent_app_number] => 10/467719 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9421 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/903/06903111.pdf [firstpage_image] =>[orig_patent_app_number] => 10467719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367994 [patent_doc_number] => 20040092533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Imidazo-pyrimidine derivatives as ligands for gaba receptors' [patent_app_type] => new [patent_app_number] => 10/472680 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34039 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092533.pdf [firstpage_image] =>[orig_patent_app_number] => 10472680 [rel_patent_id] =>[rel_patent_doc_number] =>)